Skip to content

The research on the process of emmetropization in children

The research on the process of emmetropization in children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071617
Enrollment
Unknown
Registered
2023-05-19
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

Low concentration atropine group:Low concentration atropine(0.01%/0.02%/0.05%)
Low -dose red light group:650nm red light(Twice a day/once in the morning/once in the evening)
Multifocal peripheral retinal defocus lens group:Multifocal peripheral retinal defocus lens(Hyperopia defocus/Myopic defocus)

Sponsors

Qingdao Eye Hospital of Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 8 Years

Inclusion criteria

Inclusion criteria: 1. 3 years old = age <8 years old 2. Parents are all myopia 3. The growth rate of the eye axis in the past six months is =0.2mm, or the felling speed of the end of the view is almost half a year =0.25d 4. The current refractive (equivalent spherical mirror) is between+0.75d ~ -0.5D 5. Swilish =0.75D 6. No amblyopia, strabismus and other organic lesions 7. No medical intervention measures have not been taken yet

Exclusion criteria

Exclusion criteria: 1.There are other ocular diseases that affect vision or refractive errors such as corneal disease, cataracts, glaucoma, macular degeneration, etc.). 2. Binocular anisometropia (equivalent spherical power difference)=1.00D, strabismus, amblyopia. 3. Any pathological changes of the eyeball or systemic diseases. 4. Patients with halo, tics cured, ADHD cured, and psoriasis patients. 5. Those who have used myopia control treatment methods within 3 months, such as atropine, orthokeratology lens, multifocal soft lens, multifocal hard lens, functional frame glasses. 6. Other reasons that study doctors consider inappropriate for inclusion in the program.

Design outcomes

Primary

MeasureTime frame
Diopter;axial length?K1/K2;

Secondary

MeasureTime frame
vision acuity;binocular vision(accommodation,stereopsis);retina diopter;choroid blood flow and thickness;mf-ERG?mf-VEP;

Countries

China

Contacts

Public Contactzhangjing

Qingdao Eye Hospital of Shandong First Medical University

kabbhh@126.com+86 158 9882 5081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026